首页> 外文期刊>Virology Journal >Evaluation of human enterovirus 71 and coxsackievirus A16 specific immunoglobulin M antibodies for diagnosis of hand-foot-and-mouth disease
【24h】

Evaluation of human enterovirus 71 and coxsackievirus A16 specific immunoglobulin M antibodies for diagnosis of hand-foot-and-mouth disease

机译:评估人类肠道病毒71和柯萨奇病毒A16特异性免疫球蛋白M抗体诊断手足口病

获取原文
           

摘要

Background Hand-foot-and-mouth disease (HFMD) is caused mainly by the human enterovirus type 71 (HEV71) and the Coxsackievirus A group type 16 (CVA16). Large outbreaks of disease have occurred frequently in the Asia-Pacific region. Reliable methods are needed for diagnosis of HFMD in childen. IgM-capture ELISA, with its notable advantages of convenience and low cost, provides a potentially frontline assay. We aimed to evaluate the newly developed IgM-capture ELISAs for HEV71 and CVA16 in the diagnosis of HFMD, and to measure the kinetics of IgM over the course of HEV71 or CVA16 infections. Results We mapped, for the first time, the kinetics of IgM in HEV71 and CVA16 infection. HEV71- and CVA16-IgM were both detectable in some patients on day 1 of illness, and in 100% of patients by day 5 (HEV71) and day 8 (CVA16) respectively; both IgMs persisted for several weeks. The IgM detection rates were 90.2% (138 of 153 sera) and 68.0% (66 of 97 sera) for HEV71 and CVA16 infections, respectively, during the first 7 days of diseases. During the first 90 days after onset these values were 93.6% (233 of 249 sera) and 72.8% (91 of 125 sera) for HEV71 and CVA16 infections, respectively. Some cross-reactivity was observed between HEV71- and CVA16-IgM ELISAs. HEV71-IgM was positive in 38 of 122 (31.1%) CVA16 infections, 14 of 49 (28.6%) other enteroviral infections and 2 of 105 (1.9%) for other respiratory virus infected sera. Similarly, CVA16-IgM was apparently positive in 58 of 211 (27.5%) HEV71 infections, 16 of 48 (33.3%) other enterovirus infections and 3 of 105 (2.9%) other respiratory virus infected sera. Nevertheless, the ELISA yielded the higher OD450 value of main antibody than that of cross-reaction antibody, successfully identifying the enteroviral infection in 96.6% (HEV71) and 91.7% (CVA16) cases. When blood and rectal swabs were collected on the same day, the data showed that the agreement between IgM-capture ELISA and real-time RT-PCR in HEV71 was high (Kappa value = 0.729) while CVA16 somewhat lower (Kappa value = 0.300). Conclusions HEV71- and CVA16-IgM ELISAs can be deployed successfully as a convenient and cost-effective diagnostic tool for HFMD in clinical laboratories.
机译:背景技术手足口病(HFMD)主要由71型人肠病毒(HEV71)和16型柯萨奇病毒A组(CVA16)引起。亚太地区经常发生大规模的疾病暴发。需要可靠的方法来诊断儿童手足口病。 IgM捕获ELISA具有便利性和低成本的显着优势,提供了潜在的前沿检测方法。我们旨在评估针对HEV71和CVA16的最新开发的IgM捕获ELISAs,用于诊断HFMD,并测量在HEV71或CVA16感染过程中IgM的动力学。结果我们首次绘制了HEV71和CVA16感染中IgM的动力学图。在患病第1天时,某些患者中可检测到HEV71和CVA16-IgM,分别在第5天(HEV71)和第8天(CVA16)时可检测到100%的患者。两种IgM均持续了数周。在疾病的前7天中,HEV71和CVA16感染的IgM检测率分别为90.2%(153个血清中的138个)和68.0%(97个血清中的66个)。在发病后的前90天内,HEV71和CVA16感染的这些值分别为93.6%(249血清中的233)和72.8%(125血清中的91)。在HEV71-和CVA16-IgM ELISA之间观察到一些交叉反应。在122例CVA16感染中,有38例(31.1%)HEV71-IgM呈阳性;在其他肠病毒感染的49例中,有49例(28.6%)的HEV71阳性;在其他呼吸道病毒感染的血清中,有105例中的2例(1.9%)阳性。同样,CVA16-IgM在211例(27.5%)HEV71感染中的58例,48例(33.3%)其他肠病毒感染中的16例和105例(2.9%)其他呼吸道病毒感染的血清中明显为阳性。尽管如此,ELISA产生的主抗体的OD 450 值高于交叉反应抗体,成功地鉴定出96.6%(HEV71)和91.7%(CVA16)病例的肠病毒感染。当在同一天收集血液和直肠拭子时,数据显示,HEV71中IgM捕获ELISA和实时RT-PCR之间的一致性较高(Kappa值= 0.729),而CVA16较低(Kappa值= 0.300) 。结论HEV71和CVA16-IgM ELISAs可作为临床实验室中手足口病的便捷且经济有效的诊断工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号